New blood test picks up early breast cancer

	Tweet

A new blood test has been developed by an international team of scientists which can detect the very early stage of breast cancer.

The test created by a team led by a British-based researcher, could be of particular benefit to younger women, for whom current mammography scans are less effective and it also promises to be useful in identifying prostate cancer, ovarian cancer and melanoma.

The technique does this by measuring the numerous proteins to find a characteristic cancer fingerprint and in a trial with 345 women the blood test picked up 95% of cancers, and missed 5% making it much more sensitive than existing tests.

When cancer was not present, the test again correctly identified this 95% of the time and incorrectly said there was a tumour present 5% of the time.

Breast cancer remains the most common cancer for women worldwide, with 1.1 million new cases and an estimated 300,000-400,000 deaths occurring each year.

Early detection and effective therapy are critical to the survival rate and at present a diagnosis relies on triple testing - breast examination, imaging with mammography and ultrasonography, and a biopsy.

Accurate blood testing could reduce the need for open biopsy, say the scientists.

According to the researchers the new blood test which measures the blood markers of cancer has been shown to be 200 to 1,000 times more sensitive than existing tests.

The blood test detects very small changes in concentrations of proteins in the blood and while some of the proteins are specific for breast tissue, others fluctuate with many types of cancers and are markers of inflammation and new blood vessel growth in response to the tumour.

Professor Jasminka Godovac-Zimmermann, of University College London, who led the research group, says the pilot studies demonstrated that by using blood samples, breast cancer and several other types of epithelial cancers can be detected with much more sensitivity and specificity.

The professor says this may mean less intrusive, safer and much less expensive approaches for the early diagnosis of cancer, and for distinguishing malignant and benign cancers, and for monitoring cancer therapy.

The team included scientists from the University of Pennsylvania, the University of Pittsburgh and BioTraces Inc, a company based in Herndon, Virginia.

They are now exploring how many, and which combinations of protein markers would be needed to screen for several cancers simultaneously in one blood test.

They say further research involving an independent group of patients and healthy volunteers is now needed to validate these results, and to find out if the test is equally accurate for diagnosing early breast cancer as well as advanced disease.

The study is published in the American Chemical Society’s Journal of Proteome Research reports.

RELATED STORIES:
Breast cancer screening may fuel over diagnosis   Watercress may ‘turn off’ breast cancer signal   Exercise, green tea may lessen breast cancer blues   Genetic ‘hotspot’ for breast cancer risk   Researchers suggest new paradigm for breast cancer screening   Early-Stage Breast Cancer Patients Who Receive Neoadjuvant Therapy   Breast cancer radiotherapy gentler on the heart   Eisai says drug active in advanced breast cancer   MRI May Be Noninvasive Method to Measure Breast Cancer Prognosis   New breast cancer guidelines “unsafe”: women   Evista protects against breast cancer   PI3K/mTOR pathway proteins tied to poor prognosis in breast cancer   Link Found Between Vegetables and Decreased Risk of Breast Cancer   Osteo Drug Stops Bone Loss From Breast Cancer Chemo   Study finds race affects African American survival of breast cancer   Estrogen Benefit in Breast Cancer Affirmed   High CTC levels predicted poor outcome in metastatic breast cancer   Mechanisms Involved with Tumor Relapse Identified   Peaches, plums induce deliciously promising death of breast cancer cells   Exercise boosts well-being after breast cancer   Team identifies new breast cancer tumor suppressor and how it works   Intervention Program Helps Breast Cancer Patients Live Longer After Recurrence

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]